See more : Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Dialogue Health Technologies Inc. (CARE.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dialogue Health Technologies Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- The Chemours Company (0HWG.L) Income Statement Analysis – Financial Results
- Wemade Co.,Ltd. (112040.KQ) Income Statement Analysis – Financial Results
- Foshan Electrical and Lighting Co.,Ltd (200541.SZ) Income Statement Analysis – Financial Results
- Lundin Mining Corporation (LUMI.ST) Income Statement Analysis – Financial Results
- Andhra Cements Limited (ACL.NS) Income Statement Analysis – Financial Results
Dialogue Health Technologies Inc. (CARE.TO)
About Dialogue Health Technologies Inc.
Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance, and occupational health and safety programs. It serves employers and organizations. Dialogue Technologies Inc. was founded in 2016 and is headquartered in Montreal, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 87.13M | 68.05M | 35.80M | 10.09M | 4.01M |
| Cost of Revenue | 43.79M | 39.24M | 21.41M | 4.60M | 3.05M |
| Gross Profit | 43.34M | 28.81M | 14.39M | 5.49M | 963.39K |
| Gross Profit Ratio | 49.75% | 42.33% | 40.20% | 54.37% | 24.01% |
| Research & Development | 10.52M | 9.52M | 4.72M | 3.17M | 2.80M |
| General & Administrative | 46.06M | 34.21M | 20.37M | 8.69M | 4.93M |
| Selling & Marketing | 12.73M | 11.70M | 9.43M | 5.38M | 2.92M |
| SG&A | 58.79M | 45.91M | 29.80M | 14.07M | 7.85M |
| Other Expenses | 0.00 | -225.42M | 380.53K | 217.65K | 0.00 |
| Operating Expenses | 69.31M | 55.43M | 34.52M | 17.24M | 10.66M |
| Cost & Expenses | 113.10M | 94.67M | 55.93M | 21.85M | 13.71M |
| Interest Income | 1.23M | 752.87K | 295.37K | 161.99K | 0.00 |
| Interest Expense | 114.00K | 201.78K | 503.16K | 242.63K | 387.66K |
| Depreciation & Amortization | 4.66M | 3.19M | 1.71M | 673.68K | 136.67K |
| EBITDA | -21.31M | -23.43M | -18.42M | -11.08M | -9.56M |
| EBITDA Ratio | -24.46% | -34.44% | -51.44% | -109.86% | -238.20% |
| Operating Income | -25.97M | -26.62M | -20.13M | -11.76M | -9.69M |
| Operating Income Ratio | -29.81% | -39.12% | -56.22% | -116.54% | -241.54% |
| Total Other Income/Expenses | 994.00K | -225.05M | -333.37K | -285.82K | -390.47K |
| Income Before Tax | -24.98M | -251.67M | -20.46M | -12.04M | -10.08M |
| Income Before Tax Ratio | -28.66% | -369.84% | -57.15% | -119.37% | -251.27% |
| Income Tax Expense | -467.00K | -322.23K | -229.24K | 139.49K | -2.82K |
| Net Income | -24.51M | -251.35M | -20.23M | -12.18M | -10.08M |
| Net Income Ratio | -28.13% | -369.37% | -56.51% | -120.75% | -251.27% |
| EPS | -0.37 | -4.48 | -0.31 | -0.19 | -0.16 |
| EPS Diluted | -0.37 | -4.48 | -0.31 | -0.19 | -0.16 |
| Weighted Avg Shares Out | 66.14M | 56.11M | 64.88M | 64.88M | 64.88M |
| Weighted Avg Shares Out (Dil) | 66.14M | 56.11M | 64.88M | 64.88M | 64.88M |
Source: https://incomestatements.info
Category: Stock Reports